The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 11, 2023

Filed:

Jul. 13, 2020
Applicants:

Purdue Research Foundation, West Lafayette, IN (US);

University of Utah, Salt Lake City, UT (US);

Inventors:

Stewart Andrew Low, West Lafayette, IN (US);

Philip S. Low, West Lafayette, IN (US);

Christopher Galliford, Silver Spring, MD (US);

Jindrich Kopecek, Salt Lake City, UT (US);

Jiyan Yang, Salt Lake City, UT (US);

Assignees:

Purdue Research Foundation, West Lafayette, IN (US);

University of Utah, Salt Lake City, UT (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 47/42 (2017.01); A61L 27/22 (2006.01); A61K 9/107 (2006.01); A61K 31/404 (2006.01); C07D 403/04 (2006.01); C07D 209/34 (2006.01); C07D 487/00 (2006.01); A61L 27/54 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); A61P 19/00 (2006.01); A61M 5/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/42 (2013.01); A61K 9/1075 (2013.01); A61K 31/404 (2013.01); A61L 27/22 (2013.01); A61L 27/227 (2013.01); A61L 27/54 (2013.01); A61M 5/002 (2013.01); A61P 19/00 (2018.01); C07K 7/06 (2013.01); C07K 7/08 (2013.01); A61L 2400/06 (2013.01); A61L 2430/02 (2013.01);
Abstract

Aspects of the present disclosure generally relate to compounds for targeting and healing bone fractures. Some of these compounds include a negatively charged oligopeptide comprising an acidic oligopeptide, a linker, which may be hydrolyzable or may be a substrate for the protease cathepsin K, and at least one molecule that promotes bone healing. In some compounds the molecule that promotes bone healing is an anabolic compound that inhibits GSK3β, in some compounds the molecule that promotes the healing of bone fracture is a pro-inflammatory agent such as PGE1. Other embodiments include methods of treating a bone fracture comprising administering a therapeutic amount of any one of the compounds disclosed herein.


Find Patent Forward Citations

Loading…